Medicus Pharma Ltd (MDCX)

Dec 10, 2025

Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Bluffton Today

Dec 10, 2025

Dec 10, 2025

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 - Victorville Daily Press

Dec 10, 2025

Dec 08, 2025

Medicus Pharma’s Warrant Inducement Agreement Announced - TipRanks

Dec 08, 2025

Dec 08, 2025

Medicus Pharma Elevates President Carolyn Bonner to CFO as Clinical Pipeline Accelerates - MyChesCo

Dec 08, 2025

Dec 08, 2025

Medicus Pharma Ltd. To Present at Brookline Capital Markets - Daytona Beach News-Journal

Dec 08, 2025

Dec 07, 2025

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE - Daytona Beach News-Journal

Dec 07, 2025

Dec 07, 2025

Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Asheville Citizen Times

Dec 07, 2025

Dec 06, 2025

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Daytona Beach News-Journal

Dec 06, 2025

Dec 05, 2025

Medicus Pharma secures $5.1 million from warrant exercise agreement By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Weatherford Democrat

Dec 05, 2025

Dec 05, 2025

Medicus Pharma Shakes Up Executive Ranks as President Takes on CFO Role - MSN

Dec 05, 2025

Dec 05, 2025

How Medicus Pharma Ltd. stock reacts to oil prices2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser

Dec 05, 2025

Dec 05, 2025

How Medicus Pharma Ltd. Equity Warrant stock trades during market volatilityJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser

Dec 05, 2025

Dec 04, 2025

Is Medicus Pharma Ltd. Equity Warrant stock attractive for retirement portfoliosTrade Risk Report & Free Long-Term Investment Growth Plans - Newser

Dec 04, 2025

Dec 04, 2025

Medicus Pharma appoints Carolyn Bonner as CFO - Pharmafile

Dec 04, 2025

Dec 04, 2025

How currency fluctuations impact Medicus Pharma Ltd. stockJuly 2025 Institutional & Momentum Based Trading Ideas - Newser

Dec 04, 2025

Dec 03, 2025

Medicus Pharma Ltd. Strengthens Leadership and Expands Clinical Trials - MSN

Dec 03, 2025

Dec 03, 2025

Medicus Pharma promotes president to chief financial officer - Pennsylvania Business Report -

Dec 03, 2025

Dec 03, 2025

Should I buy Medicus Pharma Ltd. (N460) stock before earnings seasonWeekly Risk Summary & Scalable Portfolio Growth Methods - Newser

Dec 03, 2025

Dec 03, 2025

Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch - marketscreener.com

Dec 03, 2025

Dec 03, 2025

How Medicus Pharma Ltd. (N460) stock gains from tech spendingJuly 2025 Setups & Safe Capital Allocation Plans - Newser

Dec 03, 2025

Dec 03, 2025

How big funds are accumulating Medicus Pharma Ltd. (N460) stockInsider Buying & Technical Confirmation Trade Alerts - Newser

Dec 03, 2025

Dec 03, 2025

Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosJuly 2025 Pullbacks & Expert Verified Movement Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Medicus Pharma shares updates on basal cell carcinoma trials - Pharmafile

Dec 02, 2025

Dec 02, 2025

Medicus Pharma appoints Carolyn Bonner as CFO after Quinlan resigns By Investing.com - Investing.com Canada

Dec 02, 2025

Dec 01, 2025

Medicus Pharma appoints Bonner as president and CFO following Quinlan’s resignation - Investing.com Australia

Dec 01, 2025

Dec 01, 2025

Medicus Pharma applies for FDA priority voucher to accelerate SkinJect’s non-invasive BCC therapy - Proactive financial news

Dec 01, 2025

Dec 01, 2025

Medicus Pharma appoints Carolyn Bonner as president and CFO By Investing.com - Investing.com Nigeria

Dec 01, 2025

Dec 01, 2025

Medicus Pharma names president Carolyn Bonner as new CFO - Proactive financial news

Dec 01, 2025

Dec 01, 2025

Medicus Pharma appoints new CFO - MSN

Dec 01, 2025

Dec 01, 2025

Medicus Pharma appoints Bonner as president and CFO following Quinlan’s resignation By Investing.com - Investing.com South Africa

Dec 01, 2025

Dec 01, 2025

Medicus Pharma Ltd. Announces CFO Changes - TradingView

Dec 01, 2025

Dec 01, 2025

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President - ACCESS Newswire

Dec 01, 2025

Dec 01, 2025

Medicus Pharma appoints Carolyn Bonner as president and CFO - Investing.com

Dec 01, 2025

Dec 01, 2025

Medicus Pharma appoints Carolyn Bonner as CFO after Quinlan resigns - Investing.com India

Dec 01, 2025

Dec 01, 2025

Medicus Pharma appoints Carolyn Bonner as chief financial officer in addition to her role as president - marketscreener.com

Dec 01, 2025

Nov 30, 2025

Will Medicus Pharma Ltd. Equity Warrant stock benefit from infrastructure spendingMarket Risk Report & High Conviction Investment Ideas - BỘ NỘI VỤ

Nov 30, 2025

Nov 30, 2025

Medicus Pharma files to sell 2.68M common shares for holders - MSN

Nov 30, 2025